Navigation Links
Frost & Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low-Dose Contraceptive Patch
Date:10/16/2009

MOUNTAIN VIEW, Calif., Oct. 16 /PRNewswire/ -- Based on its annual assessment of companies making innovative contributions in healthcare, Frost & Sullivan recognizes Agile Therapeutics, Inc. (Agile) with the 2009 North American Pharmaceuticals & Biotechnology Healthcare Innovation of the Year Award for its outstanding achievements in drug development. Agile's lead product, AG200-15 with SKINFUSION(TM), offers great potential as a convenient contraceptive option. Not only does this once-per-week contraceptive patch offer maximized patient comfort, but it also provides a safe and effective method of birth control.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Of the estimated 62 million women of reproductive age in the United States, approximately 60 percent are currently using a contraceptive method to prevent pregnancy, according to the National Survey of Family Growth (NSFG). The Centers for Disease Control identifies oral contraceptives as the most popular form of birth control - used by an estimated 11.6 million American women. However, patient compliance is typically characterized as low for oral birth control pills with 19 to 47 percent of patients missing one or more pills per cycle.

"Missed doses result in decreased efficacy and may result in unwanted pregnancies," says Frost & Sullivan Research Analyst Katheryn Symank. "One way to ensure proper patient use is through the use of contraceptives with less frequent or novel dosing, which highlights the strong market opportunity for contraceptives that increase patient convenience."

Agile's AG200-15 utilizes the company's proprietary transdermal drug delivery technology, SKINFUSION(TM), in an innovative low-dose contraceptive patch that administers the proven hormonal combination of levonorges
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Frost & Sullivans 2009 Excellence in Healthcare Awards Banquet Honours Industrys Top Performers
2. Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award
3. Emergence of Newer Drug Classes to Treat Diabetes and Co-morbidities Key to Market Expansion, Reveals Frost & Sullivan
4. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
5. Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
6. Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities
7. SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination
8. Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan
9. Frost & Sullivan Recognizes Cisbio Bioassays for Technology Innovation
10. Frost & Sullivan: Lower Import Duties and Rising Customer Demand to Boost Russian Electronics Manufacturing Market
11. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , October 1, 2014 ... to software invited to engage around the theme, ,Commercial ...     Elsevier , ... products and services, will host a gathering of some ... issues and trends impacting healthcare today and in the ...
(Date:9/30/2014)... , Sept. 30, 2014 Pacific Northwest ... Summary Global Markets Direct,s, ,Pacific Northwest ... provides an overview of the Pacific Northwest Biotechnology, ... report provides comprehensive information on the current therapeutic ... with comparative analysis at various stages, therapeutics assessment ...
(Date:9/30/2014)... Proove Biosciences , the commercial ... announce a new genetic test built upon research from ... Test will provide physicians with an objective way ... levels are stratified between individuals. With this new test, ... has a genetic predisposition that will affect their pain ...
(Date:9/30/2014)... Genedata, a leading provider ... and related life science research, today announced ... Selector as its host-pathogen data analysis platform ... a European consortium dedicated to improving the ... anti-fungal drug therapies. Genedata Selector supports this ...
Breaking Biology Technology:Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 2Elsevier Healthcare and Pharmaceutical Economics Conference 2014 To Convene Industry Leaders to Discuss Top Healthcare Business Issues 3Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3
... DIEGO, Jan. 29 BioMed Realty Trust, Inc.,(NYSE: BMR ... quarter,and year ended December 31, 2007 after the market closes ... Chief Executive Officer, and Kent Griffin,Chief Financial Officer, will host ... February 29, 2008 to discuss the company,s,financial results and operations ...
... Jan. 29 QED International Associates, Inc,administrator ... 20 underlying,indexes for the HealthShares(TM) Exchange-Traded Funds, ... trading on Thursday January 31, 2008 KV,Pharmaceutical ... (Nasdaq: ARXT ) in the HealthShares(TM) ...
... to be Highlighted at Molecular Imaging Conference, ... Inc., (OTC Bulletin Board: IMDS) a pioneer in ... 2008, January 28 - 31,2008, in Dubai, United ... CD89., (Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ), ...
Cached Biology Technology:BioMed Realty Trust To Report 2007 Fourth Quarter and Year-End Results 2QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Respiratory/Pulmonary Indexes 2Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference 2Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference 3
(Date:9/30/2014)... nature as something that we enjoy when we visit a ... we think of ourselves as a part of nature? A ... a house? , The answers to these questions reflect ... our speech and in cultural artifacts. , A new Northwestern ... American Indian Center of Chicago and the Menominee tribe of ...
(Date:9/30/2014)... professor and Howard Hughes Medical Institute investigator, and ... recipients in the 2014 round of grants from ... BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative ... September 30, provides more than $3 million in ... , The BRAIN Initiative, launched last year, is ...
(Date:9/30/2014)... German . ... foods in the world. Because they grow underground, people use ... smell of truffles is not only of interest to gourmets. ... of the Goethe University Frankfurt have discovered that the smell ... are trapped inside truffle fruiting bodies. , White truffles from ...
Breaking Biology News(10 mins):The cultural side of science communication 2Salk scientists receive $3 million for BRAIN Initiative grant 2On the trail of the truffle flavor 2
... discovered in the open ocean may force scientists to rethink ... ecosystems. A paper describing the new findings appears in ... A research team led by Jonathan Zehr, a marine ... new microbe by analyzing its genetic material, even though researchers ...
... unveils new equipment to make cancer treatment safer ... National Physical Laboratory (NPL) today will help improve the ... electron linear accelerator (linac) will help ensure patients are ... treats cancer, by using ionising radiation such as high-energy ...
... lives in remarkable ways by providing food and water, ... they are experiencing loss and degradation on a massive ... water for long enough periods to support plants that ... wet year-round. The areas include marshes, swamps, bogs and ...
Cached Biology News:Mysterious microbe plays important role in ocean ecology 2Mysterious microbe plays important role in ocean ecology 3NPL unveils new equipment to make cancer treatment safer 2Value of satellites recognized for conserving wetlands 2Value of satellites recognized for conserving wetlands 3
Mouse polyclonal antibody raised against a partial recombinant TSEN2. NCBI Entrez Gene ID = 80746...
Mouse polyclonal antibody raised against a partial recombinant AGTRAP. NCBI Entrez Gene ID = 57085...
Mouse monoclonal antibody raised against a partial recombinant RAB11B. NCBI Entrez Gene ID = RAB11B...
... Mouse polyclonal antibody raised against ... Immunogen: SF3B2 ... a.a) partial recombinant protein with ... Accession Number: NM_006842 ...
Biology Products: